Francisco Borrego
Francisco Borrego
Biocruces Bizkaia Health Research Institute, Ikerbasque Basque Foundation for Science
Dirección de correo verificada de osakidetza.eus
Título
Citado por
Citado por
Año
Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence–derived peptides by CD94/NKG2 confers protection from natural …
F Borrego, M Ulbrecht, EH Weiss, JE Coligan, AG Brooks
The Journal of experimental medicine 187 (5), 813-818, 1998
7051998
Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells
F Borrego, J Kabat, DK Kim, L Lieto, K Maasho, J Peña, R Solana, ...
Molecular immunology 38 (9), 637-660, 2002
3082002
NK phenotypic markers and IL2 response in NK cells from elderly people
F Borrego, MC Alonso, MD Galiani, J Carracedo, R Ramirez, B Ostos, ...
Experimental gerontology 34 (2), 253-265, 1999
2791999
NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor
AG Brooks, PE Posch, CJ Scorzelli, F Borrego, JE Coligan
The Journal of experimental medicine 185 (4), 795-800, 1997
2681997
CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor
F Borrego, MJ Robertson, J Ritz, J Pena, R Solana
Immunology 97 (1), 159, 1999
2021999
Cutting edge: NKG2D is a costimulatory receptor for human naive CD8+ T cells
K Maasho, J Opoku-Anane, AI Marusina, JE Coligan, F Borrego
The Journal of Immunology 174 (8), 4480-4484, 2005
2012005
Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells
AG Brooks, F Borrego, PE Posch, A Patamawenu, CJ Scorzelli, ...
The Journal of Immunology 162 (1), 305-313, 1999
1821999
US Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma
RA de Claro, K McGinn, V Kwitkowski, J Bullock, A Khandelwal, ...
Clinical Cancer Research 18 (21), 5845-5849, 2012
1782012
The CD94/NKG2 family of receptors
F Borrego, M Masilamani, AI Marusina, X Tang, JE Coligan
Immunologic research 35 (3), 263-277, 2006
1402006
The CD300 molecules: an emerging family of regulators of the immune system
F Borrego
Blood 121 (11), 1951-1960, 2013
1382013
IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells
SJ Burgess, AI Marusina, I Pathmanathan, F Borrego, JE Coligan
The Journal of Immunology 176 (3), 1490-1497, 2006
1372006
The NKG2D receptor: immunobiology and clinical implications
SJ Burgess, K Maasho, M Masilamani, S Narayanan, F Borrego, ...
Immunologic research 40 (1), 18-34, 2008
1272008
Efficient gene transfer into the human natural killer cell line, NKL, using the Amaxa nucleofection system™
K Maasho, A Marusina, NM Reynolds, JE Coligan, F Borrego
Journal of immunological methods 284 (1-2), 133-140, 2004
1262004
Peptides isolated from HLA-Cw* 0304 confer different degrees of protection from natural killer cell-mediated lysis
F Zappacosta, F Borrego, AG Brooks, KC Parker, JE Coligan
Proceedings of the National Academy of Sciences 94 (12), 6313-6318, 1997
1171997
Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells
VR Simhadri, JF Andersen, E Calvo, SC Choi, JE Coligan, F Borrego
Blood, The Journal of the American Society of Hematology 119 (12), 2799-2809, 2012
1162012
CD94/NKG2A inhibits NK cell activation by disrupting the actin network at the immunological synapse
M Masilamani, C Nguyen, J Kabat, F Borrego, JE Coligan
The Journal of Immunology 177 (6), 3590-3596, 2006
1072006
Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the γc cytokines and TGF-β1
YP Park, SC Choi, P Kiesler, A Gil-Krzewska, F Borrego, J Weck, ...
Blood, The Journal of the American Society of Hematology 118 (11), 3019-3027, 2011
892011
The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition
LC Sullivan, CS Clements, T Beddoe, D Johnson, HL Hoare, J Lin, ...
Immunity 27 (6), 900-911, 2007
882007
Regulation of CD69 expression on human natural killer cells: differential involvement of protein kinase C and protein tyrosine kinases
F Borrego, J Peña, R Solana
European journal of immunology 23 (5), 1039-1043, 1993
881993
The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor
F Borrego, M Masilamani, J Kabat, TB Sanni, JE Coligan
Molecular immunology 42 (4), 485-488, 2005
842005
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20